Language:

Results 1 - 20 of 181,902 for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method

Results 1 2 3 4 5

Show only

Peer-reviewed Journals (153,525)

Refined by: subject: Cancer Therapies

Result Number	Material Type	Record Details and Options
1	Material Type: Article	Heterogeneity of cancer‐associated fibroblasts: Opportunities for precision medicine Cancer science, 2020-08, Vol.111 (8), p.2708-2717 [Peer Reviewed Journal] 2020 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2020 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. ;2020. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1347-9032 ;ISSN: 1349-7006 ;EISSN: 1349-7006 ;DOI: 10.1111/cas.14537 ;PMID: 32573845 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
2	Material Type: Article	Combination of CTLA-4 and PD-1 blockers for treatment of cancer Journal of experimental & clinical cancer research, 2019-06, Vol.38 (1), p.255-255, Article 255 [Peer Reviewed Journal] COPYRIGHT 2019 BioMed Central Ltd. ;COPYRIGHT 2019 BioMed Central Ltd. ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2019 ;ISSN: 1756-9966 ;ISSN: 0392-9078 ;EISSN: 1756-9966 ;DOI: 10.1186/s13046-019-1259-z ;PMID: 31196207 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
3	Material Type: Article	PD-1 blockade inhibits osteoclast formation and murine bone cancer pain The Journal of clinical investigation, 2020-07, Vol.130 (7), p.3603-3620 [Peer Reviewed Journal] COPYRIGHT 2020 American Society for Clinical Investigation ;COPYRIGHT 2020 American Society for Clinical Investigation ;Copyright American Society for Clinical Investigation Jul 2020 ;2020 American Society for Clinical Investigation 2020 American Society for Clinical Investigation ;ISSN: 0021-9738 ;EISSN: 1558-8238 ;DOI: 10.1172/jci133334 ;PMID: 32484460 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
4	Material Type: Article	Long non‑coding RNA GAS5 in human cancer (Review) Oncology letters, 2020-09, Vol.20 (3), p.2587-2594 COPYRIGHT 2020 Spandidos Publications ;COPYRIGHT 2020 Spandidos Publications ;Copyright Spandidos Publications UK Ltd. 2020 ;Copyright: © Yang et al. 2020 ;ISSN: 1792-1074 ;EISSN: 1792-1082 ;DOI: 10.3892/ol.2020.11809 ;PMID: 32782576 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
5	Material Type: Article	EORTC-1203-GITCG - the "INNOVATION"-trial: Effect of chemotherapy alone versus chemotherapy plus trastuzumab, versus chemotherapy plus trastuzumab plus pertuzumab, in the perioperative treatment of HER2 positive, gastric and gastroesophageal junction adenocarcinoma on pathologic response rate: a randomized phase II-intergroup trial of the EORTC-Gastrointestinal Tract Cancer Group, Korean Cancer Study Group and Dutch Upper GI-Cancer group BMC cancer, 2019-05, Vol.19 (1), p.494-494, Article 494 [Peer Reviewed Journal] COPYRIGHT 2019 BioMed Central Ltd. ;COPYRIGHT 2019 BioMed Central Ltd. ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2019 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-019-5675-4 ;PMID: 31126258 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
6	Material Type: Article	Mismatch repair deficiency/microsatellite instability-high as a predictor for anti-PD-1/PD-L1 immunotherapy efficacy Journal of hematology and oncology, 2019-05, Vol.12 (1), p.54-54, Article 54 [Peer Reviewed Journal] COPYRIGHT 2019 BioMed Central Ltd. ;COPYRIGHT 2019 BioMed Central Ltd. ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2019 ;ISSN: 1756-8722 ;EISSN: 1756-8722 ;DOI: 10.1186/s13045-019-0738-1 ;PMID: 31151482 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
7	Material Type: Article	Hypoxic BMSC-derived exosomal miRNAs promote metastasis of lung cancer cells via STAT3-induced EMT Molecular cancer, 2019-03, Vol.18 (1), p.40-40, Article 40 [Peer Reviewed Journal] COPYRIGHT 2019 BioMed Central Ltd. ;Copyright © 2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2019 ;ISSN: 1476-4598 ;EISSN: 1476-4598 ;DOI: 10.1186/s12943-019-0959-5 ;PMID: 30866952 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
8	Material Type: Article	Targeting interleukin-6 as a strategy to overcome stroma-induced resistance to chemotherapy in gastric cancer Molecular cancer, 2019-03, Vol.18 (1), p.68-68, Article 68 [Peer Reviewed Journal] COPYRIGHT 2019 BioMed Central Ltd. ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2019 ;ISSN: 1476-4598 ;EISSN: 1476-4598 ;DOI: 10.1186/s12943-019-0972-8 ;PMID: 30927911 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
9	Material Type: Article	Exosome-based immunotherapy: a promising approach for cancer treatment Molecular cancer, 2020-11, Vol.19 (1), p.1-160, Article 160 [Peer Reviewed Journal] COPYRIGHT 2020 BioMed Central Ltd. ;2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;ISSN: 1476-4598 ;EISSN: 1476-4598 ;DOI: 10.1186/s12943-020-01278-3 ;PMID: 33183286 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
10	Material Type: Article	Classification of circulating tumor cells by epithelial-mesenchymal transition markers PloS one, 2015-04, Vol.10 (4), p.e0123976-e0123976 [Peer Reviewed Journal] COPYRIGHT 2015 Public Library of Science ;COPYRIGHT 2015 Public Library of Science ;2015 Wu et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2015 Wu et al 2015 Wu et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0123976 ;PMID: 25909322 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
11	Material Type: Article	Second Primary Cancers following Colorectal Cancer in Sicily, Italy Cancers, 2022-10, Vol.14 (21), p.5204 [Peer Reviewed Journal] COPYRIGHT 2022 MDPI AG ;2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2022 by the authors. 2022 ;ISSN: 2072-6694 ;EISSN: 2072-6694 ;DOI: 10.3390/cancers14215204 ;PMID: 36358623 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
12	Material Type: Article	Plasma free amino acid profiling of five types of cancer patients and its application for early detection PloS one, 2011-09, Vol.6 (9), p.e24143-e24143 [Peer Reviewed Journal] COPYRIGHT 2011 Public Library of Science ;COPYRIGHT 2011 Public Library of Science ;2011 Miyagi et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: https://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Miyagi et al. 2011 ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0024143 ;PMID: 21915291 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
13	Material Type: Article	The role of PD-L1 expression as a predictive biomarker: an analysis of all US Food and Drug Administration (FDA) approvals of immune checkpoint inhibitors Journal for immunotherapy of cancer, 2019-10, Vol.7 (1), p.278-278, Article 278 [Peer Reviewed Journal] The Author(s). ;COPYRIGHT 2019 BioMed Central Ltd. ;COPYRIGHT 2019 BioMed Central Ltd. ;2019 The Author(s). Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License ( http://creativecommons.org/licenses/by/4.0/ ), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/ ) applies to the data made available in this article, unless otherwise stated. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2019 ;ISSN: 2051-1426 ;EISSN: 2051-1426 ;DOI: 10.1186/s40425-019-0768-9 ;PMID: 31655605 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
14	Material Type: Article	Challenges and potential of PD-1/PD-L1 checkpoint blockade immunotherapy for glioblastoma Journal of experimental & clinical cancer research, 2019-02, Vol.38 (1), p.87-13, Article 87 [Peer Reviewed Journal] COPYRIGHT 2019 BioMed Central Ltd. ;COPYRIGHT 2019 BioMed Central Ltd. ;Copyright © 2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2019 ;ISSN: 1756-9966 ;ISSN: 0392-9078 ;EISSN: 1756-9966 ;DOI: 10.1186/s13046-019-1085-3 ;PMID: 30777100 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
15	Material Type: Article	Chronic kidney disease in cancer patients, the analysis of a large oncology database from Eastern Europe PloS one, 2022-06, Vol.17 (6), p.e0265930-e0265930 [Peer Reviewed Journal] COPYRIGHT 2022 Public Library of Science ;2022 Ciorcan et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2022 Ciorcan et al 2022 Ciorcan et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0265930 ;PMID: 35679539 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
16	Material Type: Article	Nanotechnology in cancer diagnosis: progress, challenges and opportunities Journal of hematology and oncology, 2019-12, Vol.12 (1), p.137-137, Article 137 [Peer Reviewed Journal] COPYRIGHT 2019 BioMed Central Ltd. ;COPYRIGHT 2019 BioMed Central Ltd. ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2019 ;ISSN: 1756-8722 ;EISSN: 1756-8722 ;DOI: 10.1186/s13045-019-0833-3 ;PMID: 31847897 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
17	Material Type: Article	Portrait of a cancer: mutational signature analyses for cancer diagnostics BMC cancer, 2019-05, Vol.19 (1), p.457-457, Article 457 [Peer Reviewed Journal] COPYRIGHT 2019 BioMed Central Ltd. ;COPYRIGHT 2019 BioMed Central Ltd. ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2019 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-019-5677-2 ;PMID: 31092228 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
18	Material Type: Article	Long non-coding RNAs regulate drug resistance in cancer Molecular cancer, 2020-03, Vol.19 (1), p.54-13, Article 54 [Peer Reviewed Journal] COPYRIGHT 2020 BioMed Central Ltd. ;2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;ISSN: 1476-4598 ;EISSN: 1476-4598 ;DOI: 10.1186/s12943-020-01162-0 ;PMID: 32164712 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
19	Material Type: Article	Breaking Down the Barriers to Precision Cancer Nanomedicine Trends in biotechnology (Regular ed.), 2017-02, Vol.35 (2), p.159-171 [Peer Reviewed Journal] Elsevier Ltd ;2016 Elsevier Ltd ;Copyright © 2016 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Feb 01, 2017 ;ISSN: 0167-7799 ;EISSN: 1879-3096 ;DOI: 10.1016/j.tibtech.2016.07.006 ;PMID: 27492049 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
20	Material Type: Article	BMI-1, a promising therapeutic target for human cancer Oncology letters, 2015-08, Vol.10 (2), p.583-588 [Peer Reviewed Journal] Copyright © 2015, Spandidos Publications ;COPYRIGHT 2015 Spandidos Publications ;COPYRIGHT 2015 Spandidos Publications ;Copyright Spandidos Publications UK Ltd. 2015 ;Copyright © 2015, Spandidos Publications 2015 ;ISSN: 1792-1074 ;EISSN: 1792-1082 ;DOI: 10.3892/ol.2015.3361 ;PMID: 26622537 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by